Welcome, Guest. Please login or register.
July 14, 2024, 12:41:11 pm

Login with username, password and session length

  • Total Posts: 55130
  • Total Topics: 4851
  • Online Today: 237
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 133
Total: 133


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Could a Therapeutic Vaccine Help Cure Hepatitis B?  (Read 8287 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Could a Therapeutic Vaccine Help Cure Hepatitis B?
« on: December 09, 2019, 11:42:56 am »
The experimental NASVAC vaccine led to a reduction in hepatitis B surface antigen (HBsAg) levels, and a small number of study participants achieved a functional cure, researchers reported at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases (AASLD), taking place this week in Boston.

Approved hepatitis B prevention vaccines contain HBsAg and trigger the production of antibodies against this protein, known as anti-HBs. Although generally effective, some people do not achieve protective antibody levels. Targeting additional HBV antigens could lead to stronger immune responses that are beneficial for both prevention and treatment. An experimental prevention vaccine called Sci-Vac-B, which contains three different HBV proteins, was recently shown to offer greater protection, especially for older adults and those with weak immune systems.

For more...


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.